Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Panse, Jens  [Clear All Filters]
2024
de Latour RPeffault, Röth A, Kulasekararaj AG, Han B, Scheinberg P, Maciejewski JP, Ueda Y, de Castro CM, Di Bona E, Fu R, et al. Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria. N Engl J Med. 2024;390(11):994-1008.
Naumann N, Rudelius M, Lübke J, Christen D, Bresser J, Sotlar K, Metzgeroth G, Fabarius A, Hofmann W-K, Panse J, et al. Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in D816V-Negative Advanced Systemic Mastocytosis. Cancers (Basel). 2024;16(3).
Lommerse IN, Hinnen C, van Vliet LM, Schubert B, Panse J, Halkes CJM, Tjon JM-L. Quality of life after immune suppressive therapy in aplastic anemia. Ann Hematol. 2024.
Patriquin CJ, Bogdanovic A, Griffin M, Kelly RJ, Maciejewski JP, Mulherin B, de Latour RPeffault, Röth A, Selvaratnam V, Szer J, et al. Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study. Adv Ther. 2024.
2023
Gotlib J, Castells M, Elberink HOude, Siebenhaar F, Hartmann K, Broesby-Olsen S, George TI, Panse J, Alvarez-Twose I, Radia DH, et al. Avapritinib versus Placebo in Indolent Systemic Mastocytosis. NEJM Evid. 2023;2(6):EVIDoa2200339.
Teschner D, Berisha M, Panse J, Schmitt T, Fiegle E, Naendrup J-H, Neitz J, Schmidt-Hieber M, Hentrich M, Böll B, et al. Chlorhexidine gluconate-coated gel pad dressings for prevention of central venous catheter-related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry-based matched-pair analysis. Eur J Haematol. 2023.
Röth A, Ichikawa S, Ito Y, Kim JSeok, Nagy Z, Obara N, Panse J, Schrezenmeier H, Sica S, Soret J, et al. Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial. Eur J Haematol. 2023.
Panse J, Wilson K, Fishman J, Wojciechowski P, Wdowiak M, Horneff R, Patriquin CJ, Oliver M, Hakimi Z. Fatigue and health-related quality of life in paroxysmal nocturnal haemoglobinuria: a post-hoc analysis of the pegcetacoplan PEGASUS trial data. Eur J Haematol. 2023.
Tometten M, Kirschner M, Meyer R, Begemann M, Halfmeyer I, Vieri M, Kricheldorf K, Maurer A, Platzbecker U, Radsak M, et al. Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria. Hemasphere. 2023;7(5):e874.
Hentrich M, Böll B, Teschner D, Panse J, Schmitt T, Naendrup J-H, Schmidt-Hieber M, Neitz J, Fiegle E, Schalk E. Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry. Infection. 2023.
Mause ERVander, Baker JM, Dietze KA, Radhakrishnan SV, Iraguha T, Omili D, Davis P, Chidester SL, Modzelewska K, Panse J, et al. Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity. Sci Transl Med. 2023;15(705):eadd7900.
Schalk E, Panse J. Which trial do we need? Scheduled central venous catheter (CVC) removal vs. routine clinical care for prevention of CVC-related bloodstream infections in patients with haematological malignancies. Clin Microbiol Infect. 2023.
2022
de Latour RPeffault, Szer J, Weitz IC, Röth A, Höchsmann B, Panse J, Usuki K, Griffin M, Kiladjian J-J, de Castro CM, et al. Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial. Lancet Haematol. 2022;9(9):e648-e659.
2021
Aberer E, Sperr WR, Bretterklieber A, Avian A, Hadzijusufovic E, Kluin-Nelemans HC, Elberink HOude, van Anrooij B, Niedoszytko M, Lange M, et al. Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis (ECNM). J Invest Dermatol. 2021.
Hillmen P, Szer J, Weitz I, Röth A, Höchsmann B, Panse J, Usuki K, Griffin M, Kiladjian J-J, de Castro C, et al. Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria. N Engl J Med. 2021;384(11):1028-1037.
2020
Schwaab J, Hartmann NCabral do, Naumann N, Jawhar M, Weiß C, Metzgeroth G, Schmid A, Lübke J, Reiter L, Fabarius A, et al. Importance of adequate diagnostic work-up for correct diagnosis of advanced systemic mastocytosis. J Allergy Clin Immunol Pract. 2020.
2019
Biehl LM, Higgins P, Wille T, Peter K, Hamprecht A, Peter S, Dörfel D, Vogel W, Häfner H, Lemmen S, et al. Impact of single room contact precautions on hospital-acquisition and transmission of multidrug-resistant Escherichia coli: a prospective multicentre cohort-study in haematological and oncological wards. Clin Microbiol Infect. 2019.
2016
Molderings GJ, Haenisch B, Brettner S, Homann J, Menzen M, Dumoulin FLudwig, Panse J, Butterfield J, Afrin LB. Pharmacological treatment options for mast cell activation disease. Naunyn Schmiedebergs Arch Pharmacol. 2016.
2014
Emontzpohl C, Goetzenich A, Simons D, Kraemer S, Dewor M, Lue H, Hammer L, Jacobs D, Grieb G, Ziegler P, et al. Key role of MIF in the migration of endothelial progenitor cells in patients during cardiac surgery. Int J Cardiol. 2014;181C:284-287.